These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

374 related items for PubMed ID: 4371312

  • 21. Methanol extraction residue fraction of tubercle bacilli (MER) and other mycobacterial extracts as systemic immunity adjuvants in cancer immunotherapy.
    Mathé G, Hiu IJ, Halle-Pannenko O, Bourut C.
    Isr J Med Sci; 1976; 12(4-5):468-71. PubMed ID: 820673
    [Abstract] [Full Text] [Related]

  • 22. Quantitative effects of nutritional protein and calorie deficiency upon immune responses to tumors in mice.
    Jose DG, Good RA.
    Cancer Res; 1973 Apr; 33(4):807-12. PubMed ID: 4633154
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Two distinct pathways of immuno-modulation improve potency of p53 immunization in rejecting established tumors.
    Daftarian P, Song GY, Ali S, Faynsod M, Longmate J, Diamond DJ, Ellenhorn JD.
    Cancer Res; 2004 Aug 01; 64(15):5407-14. PubMed ID: 15289349
    [Abstract] [Full Text] [Related]

  • 26. Bacillus Calmette-Guerin in the treatment of neoplastic disease.
    Laucius JF, Bodurtha AJ, Mastrangelo MJ, Creech RH.
    J Reticuloendothel Soc; 1974 Dec 01; 16(6):347-73. PubMed ID: 4616079
    [No Abstract] [Full Text] [Related]

  • 27. Combined use of BCG and neuraminidase in experimental tumor immunotherapy.
    Simmons RL, Rios A.
    Surg Forum; 1971 Dec 01; 22():99-101. PubMed ID: 4941334
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Experimental studies of tumor immunotherapy. II. Tumor immunotherapy following tumor extirpation.
    Hayashi S.
    Acta Med Okayama; 1976 Jun 01; 30(3):197-208. PubMed ID: 136871
    [Abstract] [Full Text] [Related]

  • 30. Adjuvant immunochemotherapy of murine neoplasms.
    Robinson JC, Gleiber W, Graff RJ.
    Surg Forum; 1976 Jun 01; 27(62):147-50. PubMed ID: 1019835
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Modulation of antitumor immunity--immunobiologic approaches.
    North RJ, Dye ES, Mills CD, Chandler JP.
    Springer Semin Immunopathol; 1982 Jun 01; 5(2):193-220. PubMed ID: 6293113
    [No Abstract] [Full Text] [Related]

  • 37. Effect of Myobacterium bovis (strain Bacillus Calmette-Guérin) on macrophage production by the bone marrow of tumor-bearing mice.
    Fisher B, Taylor S, Levine M, Saffer E, Fisher ER.
    Cancer Res; 1974 Jul 01; 34(7):1668-70. PubMed ID: 4599359
    [No Abstract] [Full Text] [Related]

  • 38. Cancer immunotherapy with surgery.
    Orita K, Miwa H, Mannami T, Konaga E, Yumura M.
    Acta Med Okayama; 1977 Aug 01; 31(4):217-34. PubMed ID: 145159
    [Abstract] [Full Text] [Related]

  • 39. Histologic and ultrastructural studies of tumor regression in inbred guinea pigs after intralesional injection of Mycobacterium bovis (BCG).
    Hanna MG, Snodgrass MJ, Zbar B, Rapp HJ.
    Natl Cancer Inst Monogr; 1973 Dec 01; 39():71-85. PubMed ID: 4362524
    [No Abstract] [Full Text] [Related]

  • 40. Effect of cell-wall skeleton of Mycobacterium bovis BCG on cell-mediated cytotoxicity in tumor-bearing mice.
    Taniyama T, Azuma I, Aladin AA, Yamamura Y.
    Gan; 1975 Dec 01; 66(6):705-9. PubMed ID: 817955
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 19.